Progyny, Inc. (NASDAQ:PGNY) Director Norman Payson sold 5,000 shares of the company's stock in a transaction on Wednesday, April 7th. The shares were sold at an average price of $44.93, for a total value of $224,650.00. Following the completion of the sale, the director now directly owns 528,446 shares in the company, valued at approximately $23,743,078.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Norman Payson also recently made the following trade(s):
- On Tuesday, March 30th, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $43.35, for a total value of $216,750.00.
- On Wednesday, March 24th, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $48.48, for a total value of $242,400.00.
- On Wednesday, March 17th, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $48.14, for a total value of $240,700.00.
- On Wednesday, March 3rd, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $42.91, for a total value of $214,550.00.
- On Wednesday, February 3rd, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $47.80, for a total value of $239,000.00.
- On Wednesday, January 27th, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $44.91, for a total value of $224,550.00.
- On Wednesday, January 20th, Norman Payson sold 5,000 shares of Progyny stock. The shares were sold at an average price of $48.53, for a total value of $242,650.00.
- On Thursday, January 14th, Norman Payson sold 10,000 shares of Progyny stock. The shares were sold at an average price of $45.12, for a total value of $451,200.00.
NASDAQ PGNY traded up $1.74 during trading hours on Friday, hitting $47.50. 510,264 shares of the company's stock were exchanged, compared to its average volume of 746,162. The business's 50 day moving average is $46.12 and its 200-day moving average is $39.19. Progyny, Inc. has a 12-month low of $18.77 and a 12-month high of $53.48. The firm has a market capitalization of $4.14 billion, a P/E ratio of 431.82 and a beta of 1.83.
Progyny (NASDAQ:PGNY) last released its earnings results on Wednesday, February 24th. The company reported $0.07 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.06 by $0.01. Progyny had a return on equity of 7.43% and a net margin of 1.03%. The firm had revenue of $100.30 million for the quarter. On average, research analysts anticipate that Progyny, Inc. will post 0.14 EPS for the current fiscal year.
A number of analysts recently commented on PGNY shares. Bank of America raised Progyny from a "neutral" rating to a "buy" rating in a research note on Tuesday, March 16th. Zacks Investment Research lowered Progyny from a "hold" rating to a "sell" rating in a research note on Saturday, February 27th. One equities research analyst has rated the stock with a sell rating and six have given a buy rating to the company. Progyny has a consensus rating of "Buy" and an average price target of $37.71.
Several institutional investors have recently added to or reduced their stakes in the company. Clearbridge Investments LLC raised its holdings in shares of Progyny by 0.4% in the 4th quarter. Clearbridge Investments LLC now owns 2,536,357 shares of the company's stock worth $107,516,000 after purchasing an additional 10,135 shares during the period. BlackRock Inc. raised its holdings in shares of Progyny by 11.8% in the 4th quarter. BlackRock Inc. now owns 2,236,439 shares of the company's stock worth $94,803,000 after purchasing an additional 235,442 shares during the period. Brown Advisory Inc. raised its holdings in shares of Progyny by 0.8% in the 4th quarter. Brown Advisory Inc. now owns 1,326,771 shares of the company's stock worth $56,242,000 after purchasing an additional 10,016 shares during the period. GW&K Investment Management LLC raised its holdings in shares of Progyny by 27.3% in the 4th quarter. GW&K Investment Management LLC now owns 846,802 shares of the company's stock worth $35,896,000 after purchasing an additional 181,412 shares during the period. Finally, Bamco Inc. NY raised its holdings in shares of Progyny by 44.1% in the 4th quarter. Bamco Inc. NY now owns 588,279 shares of the company's stock worth $24,937,000 after purchasing an additional 180,000 shares during the period. Institutional investors own 58.54% of the company's stock.
Progyny Company Profile
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Featured Article: Trading Stocks - What are percentage gainers?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
7 Great Dividend Stocks to Buy For a Comfortable RetirementThere are people who will say the day of set it and forget it retirement accounts are over. But it’s a narrative we’ve heard before. The truth is the formula for saving for and enjoying a comfortable retirement, like the formula for weight loss, hasn’t really changed. A lot depends on whether an individual has the discipline to see it through.
Dividend stocks remain one of the core elements of a retirement portfolio. As individuals near retirement the ability to reinvest dividends allows for a greater total return. And once individuals need to live off their portfolio, the dividends provide a source of income without having to tap their principal.
However, not all dividend stocks are the same and many investors get sucked in by the allure of a high-yield dividend stock. But what you’re really looking for are companies with a history of increasing its dividend. The ability to increase a dividend over time illustrates that the company has a business model that can hold up regardless of how the broader economy is performing.
In this special presentation, we’ll highlight seven stocks that individuals can buy today to capture a stable, recurring dividend.
View the "7 Great Dividend Stocks to Buy For a Comfortable Retirement".
